Study Identifies Blood, Urine Tests That Could Reduce Spinal Taps in Newborns
Researchers show the noninvasive tests can reliably identify infants with fevers 28 days and younger who are at very low risk for invasive bacterial infections.
Researchers show the noninvasive tests can reliably identify infants with fevers 28 days and younger who are at very low risk for invasive bacterial infections.
The droplet digital PCR assay shows 90.9% sensitivity and can detect previously missed cases of the bacterial infection.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
At ADLM, researchers showcase how AI is advancing clinical lab medicine—from improving early Lyme disease detection to helping teens access reliable health information.
New high-throughput panel uses advanced PCR signal detection to enable customizable respiratory virus testing from a single sample.
QuidelOrtho and BÜHLMANN Laboratories have partnered to launch the fCAL turbo and fPELA turbo fecal biomarker assays on VITROS Systems.
The test uses Abbott's simpli-COLLECT platform to detect chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium from patient-collected specimens.